Picard Medical, Inc.
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -467.4% | -113.9% | -556.1% | -296.0% | -377.0% | -361.5% | -119.2% | -548.8% | -433.8% | -330.4% | -45.8% | -254.7% | |
| – | 17.4% | 7.2% | 22.0% | 13.8% | 15.1% | 20.8% | 5.9% | 10.7% | 12.9% | 11.8% | 4.7% | 8.4% | |
| – | – | 1.6% | 28.0% | 49.4% | 27.0% | 22.7% | 8.6% | 17.2% | 22.4% | 14.3% | 46.7% | 31.3% | |
| – | 286.0% | -23.9% | -39.3% | 107.0% | 91.7% | 118.7% | 39.8% | -276.8% | -148.7% | 20.4% | 47.8% | -49.8% | |
| – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 2.3% | 0.0% | 0.4% | |
| – | – | – | – | – | – | 0.0% | 0.0% | – | – | -2.3% | – | – | |
| – | – | – | – | – | – | 80.6% | 69.7% | 1,469.6% | – | – | – | – | |
| – | – | – | – | 286.9% | 386.7% | 376.5% | 60.7% | -590.6% | 1,437.6% | -657.7% | -62.1% | -30.2% | |
| – | 435.5% | 123.6% | 508.9% | 286.9% | 386.7% | 457.1% | 106.9% | 753.9% | 1,290.1% | -654.1% | 42.2% | 249.0% | |
| – | 29.5% | 8.4% | -47.8% | -8.2% | 10.8% | 95.5% | -13.0% | 202.4% | 856.1% | -985.2% | -2.8% | -5.9% | |
| – | -467.4% | -113.9% | -556.1% | -296.0% | -377.0% | -361.5% | -119.2% | -548.8% | -433.8% | -332.7% | -45.8% | -255.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.